EZH2 copy number gain as a therapeutic target in mucosal melanoma

被引：0
|
作者：
Yu, Huan
Kong, Yan
Yan, Junya
Ma, Meng
Xu, Longwen
Yu, Jiayi
Xu, Tianxiao
Dai, Jie
Tang, Huan
Wu, Xiaowen
Chi, Zhihong
Si, Lu
Shen, Xinan
Tang, Bixia
Lian, Bin
Wang, Xuan
Li, Siming
Bai, Xue
Guo, Jun
机构：
[1] Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Beijing, Peoples R China
[3] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst,Dept Renal Canc & Melanoma, Collaborat Innovat Ctr Canc Med,Minist Educ Beiji, Beijing 100142, Peoples R China
[4] Beijing Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21530
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] Role of the Epigenetic Modifier EZH2 in Melanoma
    Zingg, D.
    Schaefer, S.
    Cheng, P.
    Shakhova, O.
    Chin, L.
    Beermann, F.
    Koseki, H.
    Dummer, R.
    Sommer, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 43 - 44
  • [42] EZH2 -mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
    Hou, Chen
    Xiao, Lirong
    Ren, Xiang
    Cheng, Lin
    Guo, Bo
    Zhang, Meixia
    Yan, Naihong
    FRONTIERS IN GENETICS, 2022, 13
  • [43] EZH2 as a Potential Target for NAFLD Therapy
    Lim, Hyun Jung
    Kim, Mirang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 15
  • [44] Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA
    Ricke, Brandon
    Shah, Kushal
    Salacz, Michael
    Camarata, Paul
    Lovick, Darren
    Peng, Warner
    Dolatkhah, Roya
    Sanaat, Zohreh
    Kimura, Kyle
    Bi, Danse
    Taylor, Sarah
    Esfandyari, Tuba
    Farassati, Faris
    NEURO-ONCOLOGY, 2015, 17 : 36 - 36
  • [45] EZH2 as a potential target in cancer therapy
    McCabe, Michael T.
    Creasy, Caretha L.
    EPIGENOMICS, 2014, 6 (03) : 341 - 351
  • [46] EZH2: a novel target for cancer treatment
    Duan, Ran
    Du, Wenfang
    Guo, Weijian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [47] EZH2: a novel target for cancer treatment
    Ran Duan
    Wenfang Du
    Weijian Guo
    Journal of Hematology & Oncology, 13
  • [48] OVEREXPRESSION OF Ezh2 AS A TARGET IN TREATMENT OF GLIOMA
    Farassati, Faris
    Peng, Warner
    Lovick, Darren
    Shah, Kushal
    Ricke, Brandon
    NEURO-ONCOLOGY, 2016, 18 : 59 - 60
  • [49] Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy
    Huan Yu
    Meng Ma
    Junya Yan
    Longwen Xu
    Jiayi Yu
    Jie Dai
    Tianxiao Xu
    Huan Tang
    Xiaowen Wu
    Siming Li
    Bin Lian
    Lili Mao
    Zhihong Chi
    Chuanliang Cui
    Jun Guo
    Yan Kong
    Journal of Translational Medicine, 15
  • [50] EZH2 as molecular target for Glioblastoma treatment
    Scheffler, J.
    Freitag, T.
    Ramtke, J.
    Kaps, P.
    Dubinski, D.
    Junghanss, C.
    Maletzki, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 89 - 89
12345